Insider Buying: Chemours (NYSE:CC) CEO Purchases $50,501.10 in Stock

The Chemours Company (NYSE:CC) CEO Denise Dignam bought 3,378 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average price of $14.95 per share, for a total transaction of $50,501.10. Following the completion of the purchase, the chief executive officer directly owned 339,916 shares in the company, valued at $5,081,744.20. The trade was a 1.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Chemours Stock Performance

Shares of CC opened at $15.81 on Friday. The company has a market capitalization of $2.38 billion, a PE ratio of -8.28 and a beta of 1.43. The Chemours Company has a one year low of $10.44 and a one year high of $28.67. The company has a debt-to-equity ratio of 18.98, a current ratio of 1.66 and a quick ratio of 0.88. The company’s fifty day moving average price is $18.54 and its 200 day moving average price is $20.00.

Chemours (NYSE:CC) last released its earnings results on Tuesday, August 4th. The specialty chemicals company reported $0.42 earnings per share for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.07). The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.65 billion. Chemours had a positive return on equity of 60.64% and a negative net margin of 5.00%.The firm’s revenue was down 1.5% on a year-over-year basis. During the same period in the prior year, the firm earned ($2.54) EPS. As a group, analysts expect that The Chemours Company will post 0.88 earnings per share for the current year.

Chemours Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Friday, August 14th will be given a dividend of $0.0875 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $0.35 dividend on an annualized basis and a yield of 2.2%. Chemours’s payout ratio is -18.32%.

More Chemours News

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Chemours is expanding its low-GWP Opteon refrigerant portfolio to address rising cooling demand from AI-driven data centers. The initiative could support growth in a higher-demand market while aligning with customers’ decarbonization goals. Zacks article on Chemours refrigerants for data centers
• Positive Sentiment: CEO Denise Dignam bought 3,378 shares for approximately $50,500, while insider Gerardo Familiar Calderon purchased 1,935 shares for roughly $30,000. The open-market purchases may suggest that insiders view the recent share-price weakness as an opportunity. SEC filing on CEO purchase SEC filing on insider purchase
• Neutral Sentiment: BMO Capital Markets cut its price target from $26 to $18 but maintained an “outperform” rating, leaving implied upside while signaling reduced expectations. The broader analyst consensus remains “hold,” with an average target near $20.10.
• Negative Sentiment: A securities-fraud investigation involving Chemours was announced, creating a potential legal and reputational overhang for shareholders. The announcement does not establish wrongdoing, but it may increase uncertainty around the company.
• Negative Sentiment: JPMorgan lowered its price target from $22 to $15 and kept a “neutral” rating, while Zacks Research downgraded the stock from “strong buy” to “strong sell.” These actions reinforce concerns following Chemours’ recent quarterly EPS and revenue misses. Benzinga report on JPMorgan target cut Zacks rating report

Institutional Trading of Chemours

Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Chemours in the second quarter valued at approximately $477,769,000. Vanguard Group Inc. grew its position in Chemours by 2.8% during the 4th quarter. Vanguard Group Inc. now owns 17,920,868 shares of the specialty chemicals company’s stock worth $211,287,000 after acquiring an additional 490,778 shares during the last quarter. State Street Corp grew its position in Chemours by 22.7% during the 2nd quarter. State Street Corp now owns 6,114,328 shares of the specialty chemicals company’s stock worth $70,009,000 after acquiring an additional 1,131,682 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in Chemours by 13.8% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,796,153 shares of the specialty chemicals company’s stock valued at $75,971,000 after purchasing an additional 580,089 shares in the last quarter. Finally, UBS Group AG increased its holdings in Chemours by 0.3% during the 3rd quarter. UBS Group AG now owns 4,754,492 shares of the specialty chemicals company’s stock valued at $75,311,000 after purchasing an additional 14,865 shares in the last quarter. 76.26% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Mizuho set a $22.00 target price on Chemours in a research note on Wednesday, August 5th. JPMorgan Chase & Co. dropped their target price on Chemours from $22.00 to $15.00 and set a “neutral” rating for the company in a report on Thursday. Alembic Global Advisors restated an “overweight” rating and set a $30.00 target price on shares of Chemours in a research report on Wednesday, May 13th. Truist Financial decreased their price target on Chemours from $30.00 to $24.00 and set a “buy” rating on the stock in a research note on Thursday, August 6th. Finally, UBS Group reiterated a “neutral” rating and issued a $18.00 price target (down from $29.00) on shares of Chemours in a research report on Monday, August 10th. Five equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $20.10.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.